Featured Science from Wednesday, Feb. 22
Main Event I: Opening Session
10:30 a.m. to 12:00 p.m. - Hall C
Featured Posters from Wednesday, Feb. 22
Late-Breaking Science Posters I
6:15 p.m. to 6:45 p.m. - Hall E
Featured Science from Thursday, Feb. 23
Thursday Main Event
11:00 a.m. to 12:00 p.m. - Hall C
Late-Breaking Science Oral Abstracts I
1:30 p.m. to 3:00 p.m. - Grand Ballroom B
Featured Science from Friday, Feb. 24
Closing Main Event
10:30 a.m. to 12:30 p.m. - Hall C
The Council on Peripheral Vascular Disease (PVD) seeks to integrate the academic and clinical missions of all interdisciplinary vascular health professionals in order to expand professional and public vascular education; to advance the basic science and clinical research and evidence based practice; and to thereby improve clinical outcomes of individuals with PVD.
Joshua A. Beckman, MD, MS, FAHA
Chair, Council on Peripheral Vascular Disease
The Council on Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) contributes to the mission and objectives of the American Heart Association (AHA) through efforts in the fields of arteriosclerosis, thrombosis and vascular biology. The council advances and coordinates research, addresses prevention, improves methods for diagnosis and treatment, and works actively with other organizations concerned with these issues. The council disseminates reliable information related to these fields through its annual conference, many awards and lectures, and the AHA's journal, Arteriosclerosis, Thrombosis, and Vascular Biology.
Steven R. Lentz, MD, PhD, FAHA
Chair, Council on Arteriosclerosis, Thrombosis and Vascular Biology
The purpose of the Council on Clinical Cardiology (CLCD) is to achieve the objectives of the American Heart Association (AHA) in the field of clinical cardiology, to promote excellence in clinical care and to foster the professional development and education of clinical cardiologists. Through council-sponsored symposia, panels and scientific conferences, members can access new developments in the field and interpret and promote clinical cardiology to professional and lay audiences.
Ileana L. Piña, MD, MPH, FAHA, FACC
Chair, Council on Clinical Cardiology
The American Heart Association's (AHA) strategic goal to reduce coronary heart disease, stroke and risk by 20 percent by the year 2020 has led to an emphasis on the importance of resuscitation and the chain of survival in AHA activities and use of resources. The Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation (3CPR) bench-to-bedside and community approach ranges from integrated cardiopulmonary physiology to issues of critical care, emergency cardiovascular care and CPR. Pulmonary hypertension and regulation of the pulmonary circulation have historically been areas of investigation for many of our council members. The council is keenly interested in promoting approaches that include clinical care, clinical research and basic science.
Council activities focus on developing research interests and careers of young investigators, writing scientific statements for the AHA, supporting scientific meetings and providing representation on various American Heart Association committees.
Benjamin S. Abella, MD, MPhil, FAHA
Chair, Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation